Skip to content
Corcept logo Corcept logo
Main Menu
  • Contact Us
  • About
    • About Corcept
    • Executive Team
    • Board of Directors
    • Educational Grants
    • Contact Us
  • Product
    • Korlym® for Cushing Syndrome
    • Medical Information Request
  • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Working at Corcept
    • Benefits
    • Current Opportunities
Patient riding a bike

Korlym® (mifepristone)
300 mg Tablets

Korlym Logo Mifepristone
  • Korlym Prescribing Information, including BOXED WARNING
  • Korlym Medication Guide
  • Visit Korlym.com

View information about the Corcept Access & Financial Support and Patient Advocate Program for Korlym.

To report a medical adverse event, side effect or a product complaint please call 1-855-844-3270

  • About
    • Executive Team
    • Board of Directors
    • Educational Grants
      • Contact Us
  • Product
    • Korlym for Cushing Syndrome
    • Medical Information Request
    • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Benefits
    • Current Opportunities
© 2023 Corcept
  • Privacy Notice
  • Terms of Use
  • Site Map

This website uses cookies to help us give you the best experience when you visit. By continuing to use this website, you consent to the use of these cookies. To find out more about how we use cookies and how you can manage them go to our Cookie Notice.